Synopsys Beats Q2 Estimates and Raises FY26 Guidance, but Shares Plunge 9%

Transcript intelligence

What changed

Q2 revenue of $2.276B beat the $2.251B consensus estimate by 1.1%. Non-GAAP EPS of $3.35 exceeded the $3.15 estimate by 6.3%. Non-GAAP operating margin reached 39.5%. Full-year FY26 guidance was raised for revenue, operating margin, EPS, and free cash flow. Approximately half of committed ANSYS cost synergies were achieved. The first industry HBM4 IP test chip was delivered in Q2. A new gross-basis accounting model was adopted for ANSYS channel revenue. The pending sale of the Processor IP Solutions business was announced. A cooperation agreement with Elliott Management resulted in Jesse Cohn joining the board. The stock fell 9.2% on 3x normal volume with a subsequent drift of -5.5%.

Guidance delta

Raised. Full-year FY26 guidance increased for revenue, non-GAAP operating margin, EPS, and free cash flow. Management cited continued AI-driven demand, ANSYS synergy capture, and expanding adoption of 3D-IC and multiphysics technologies as drivers.

Key takeaways

• Q2 revenue of $2.276B and non-GAAP EPS of $3.35 both exceeded consensus and guidance
• Full-year FY26 guidance raised across revenue, operating margin, EPS, and free cash flow
• AI-driven demand expanding across EDA, IP, and multiphysics with strong 3D-IC and hardware-assisted verification wins
• Multiphysics fusion and Agentic AI technologies showing early productivity gains; commercial launch slated for H2 2026
• Approximately half of committed ANSYS cost synergies achieved; integration on track
• First industry HBM4 IP test chip delivered in Q2

Management priorities

• Commercial launch of multiphysics fusion technology in H2 2026
• Further rollout of Agentic AI agents across EDA workflows
• Closing the sale of Processor IP Solutions business
• Investor Day on September 30 to detail roadmap and monetization strategies
• Continued margin expansion through cost synergies and higher-value IP contracts